Effect of Septal Ablation on Myocardial Relaxation and Left Atrial Pressure in Hypertrophic Cardiomyopathy. An Invasive Hemodynamic Study

JACC: Cardiovascular Interventions

Volumn 1, Issue 5, 2008, Pages 552-560

  Sorajja, Paul ^a   Nishimura, Rick A ^a   Ommen, Steve R ^a   Rihal, Charanjit S ^a   Gersh, Bernard J ^a   Holmes Jr , David R ^a  

^a Mayo Clinic College of Medicine   (United States)

Author keywords

diastole; hypertrophic cardiomyopathy; septal ablation

Indexed keywords

ADULT; ARTICLE; CATHETER ABLATION; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; FEMALE; HEART HEMODYNAMICS; HEART LEFT ATRIUM PRESSURE; HEART LEFT VENTRICLE FILLING PRESSURE; HEART LEFT VENTRICLE OUTFLOW TRACT; HEART LEFT VENTRICLE RELAXATION; HEART MUSCLE RELAXATION; HEART VENTRICLE SEPTUM; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; MALE; MANOMETER; POPULATION RESEARCH; PRIORITY JOURNAL;

AGED; ATRIAL FUNCTION, LEFT; CARDIOMYOPATHY, HYPERTROPHIC; CATHETER ABLATION; DIASTOLE; ECHOCARDIOGRAPHY, DOPPLER, COLOR; FEMALE; HEART CATHETERIZATION; HEMODYNAMICS; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL CONTRACTION; TREATMENT OUTCOME; VENTRICULAR FUNCTION, LEFT; VENTRICULAR PRESSURE;

EID: 54049091516     PISSN: 19368798     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcin.2008.07.004     Document Type: Article

References (33)

1. Maron B.J. Hypertrophic cardiomyopathy: a systematic review. JAMA 287 (2002) 1308-1320
2. Elliott P.M., Brecker S.J., and McKenna W.J. Diastolic dysfunction in hypertrophic cardiomyopathy. Eur Heart J 19 (1998) 1125-1127
3. Nishimura R.A., and Holmes Jr. D.R. Hypertrophic obstructive cardiomyopathy. N Engl J Med 350 (2004) 1320-1327
4. Brusaert D.L., Rademakers R.E., and Sys S.U. Triple control of myocardial relaxation: implications in cardiac disease. Circulation 69 (1984) 190-196
5. Maron M.S., Olivotto I., Betocchi S., et al. Effect of left ventricular outflow tract obstruction on clinical outcome in hypertrophic cardiomyopathy. N Engl J Med 348 (2003) 295-303
6. Nagueh S.H., Lakkkis N.M., Middleton K.J., et al. Changes in left ventricular diastolic function 6 mos after nonsurgical septal reduction therapy for hypertrophic obstructive cardiomyopathy. Circulation 99 (1999) 344-347
7. Sitges M., Shiota T., Lever H.M., et al. Comparison of left ventricular diastolic function in obstructive hypertrophic cardiomyopathy in patients undergoing percutaneous septal alcohol ablation versus surgical myotomy/myectomy. Am J Cardiol 91 (2003) 817-821
8. Rovner A., Smith R., Greenberg N.L., et al. Improvement in diastolic intraventricular pressure gradients in patients with HOCM after ethanol septal reduction. Am J Physiol Heart Circ Physiol 285 (2003) H2492-H2499
9. Faber L., Seggewiss H., Welge D., et al. Echo-guided percutaneous septal ablation for symptomatic hypertrophic obstructive cardiomyopathy: 7 years of experience. Eur J Echocardiogr 5 (2004) 347-355
10. Nagueh S.F., Ommen S.R., Lakkis N.M., et al. Comparison of ethanol septal reduction therapy with surgical myectomy for the treatment of hypertrophic cardiomyopathy. J Am Coll Cardiol 38 (2001) 1701-1706
11. Qin J.X., Shiota T., Lever H.M., et al. Outcome of patients with hypertrophic obstructive cardiomyopathy after percutaneous transluminal septal myocardial ablation and septal myectomy surgery. J Am Coll Cardiol 38 (2001) 1994-2000
12. Firoozi S., Elliott P.M., Sharma S., et al. Septal myotomy-myectomy and transcoronary septal alcohol ablation in hypertrophic cardiomyopathy. Eur Heart J 23 (2002) 1617-1624
13. Maron B.J., Dearani J.A., Ommen S.R., et al. The case for surgery in obstructive hypertrophic cardiomyopathy. J Am Coll Cardiol 44 (2004) 2044-2053
14. Hess O.M., and Sigwart U. New treatment strategies for hypertrophic obstructive cardiomyopathy. Alcohol ablation of the septum: the new gold standard?. J Am Coll Cardiol 44 (2004) 2054-2055
15. Report of the World Health Organization/International Society and Federation of Cardiology Task Force on the definition and classification of cardiomyopathies. Circulation 93 (1996) 841-842
16. Maron B.J., and Epstein S.E. Hypertrophic cardiomyopathy: a discussion of nomenclature. Am J Cardiol 43 (1979) 1242-1244
17. Panza J.A., Petrone R.K., Fananapazir L., and Maron B.J. Utility of continuous wave Doppler echocardiography in the noninvasive assessment of left ventricular outflow tract pressure gradient in patients with hypertrophic cardiomyopathy. J Am Coll Cardiol 19 (1992) 91-99
18. Zoghbi W.A., Enriquez-Sarano M., Foster E., et al. Recommendations for evaluation of the severity of native valvular regurgitation with two-dimensional and Doppler echocardiography. J Am Soc Echocardiogr 16 (2003) 777-802
19. Ommen S.R., Nishimura R.A., Appleton C.P., et al. Clinical utility of Doppler echocardiography and tissue Doppler imaging in the estimation of left ventricular filling pressures. A comparative simultaneous Doppler-catheterization study. Circulation 102 (2000) 1788-1794
20. Weiss J.L., Frederiksen J.W., and Weisfeldt M.L. Hemodynamic determinants of the time-course of fall in canine left ventricular pressure. J Clin Invest 58 (1976) 751-760
21. Sorajja P., Valeti U., Nishimura R.A., et al. Outcome of alcohol septal ablation for obstructive hypertrophic cardiomyopathy. Circulation 118 (2008) 134-139
22. Valeti U., Nishimura R.A., Holmes D.R., et al. Comparison of surgical septal myectomy and alcohol septal ablation with cardiac magnetic resonance imaging in patients with hypertrophic obstructive cardiomyopathy. J Am Coll Cardiol 49 (2007) 350-357
23. Aoyagy T., Iizuka M., Takahashi K., et al. Wall motion asynchrony prolongs time-constant of left ventricular relaxation. Am J Physiol 257 (1989) H883-H890
24. Matsubara H., Nakatani S., Nagata S., et al. Salutary effect of disopyramide on left ventricular diastolic function in hypertrophic obstructive cardiomyopathy. J Am Coll Cardiol 26 (1995) 768-775
25. Schoendube F.A., Klues H.G., Reith S., et al. Long-term clinical and echocardiographic follow-up after surgical correction of hypertrophic obstructive cardiomyopathy with extended myectomy and reconstruction of the subvalvular mitral apparatus. Circulation 92 (1995) 122-127
26. Bonow R.O., Vitale D.F., Maron B.J., et al. Regional left ventricular synchrony and impaired global left ventricular filling in hypertrophic cardiomyopathy: effect of verapamil. J Am Coll Cardiol 9 (1987) 1108-1116
27. Zile M.R., Tomita M., Nakano K., et al. Effects of left ventricular volume overload produced by mitral regurgitation on diastolic function. Am J Physiol 261 (1991) H1471-H1480
28. Zile M.R., Tomita M., Ishihara K., et al. Changes in diastolic function during development and correction of chronic LV volume overload produced by mitral regurgitation. Circulation 87 (1993) 1378-1388
29. Tsutsui H., Urabe Y., Mann D.L., et al. Effects of chronic mitral regurgitation on diastolic function in isolated cardiocytes. Circ Res 72 (1993) 1110-1123
30. Diodati J.G., Schenke W.H., Waclawis M.A., McIntosh C.L., and Cannon III R.O. Predictors of exercise benefit after operative relief of left ventricular outflow obstruction by the myotomy-myectomy procedure in hypertrophic cardiomyopathy. Am J Cardiol 69 (1992) 1617-1622
31. Mundhenke M., Schwartzkopff B., Stark P., Schulte H.D., and Strauer B.E. Myocardial collagen type I and impaired left ventricular function under exercise in hypertrophic cardiomyopathy. Thorac Cardiovasc Surg 50 (2002) 216-222
32. Van Dockum W.G., Beek A.M., ten Cate F.J., et al. Early onset and progression of left ventricular remodeling after alcohol septal ablation in hypertrophic obstructive cardiomyopathy. Circulation 111 (2005) 2503-2508
33. Geske J., Sorajja P., Nishimura R.A., and Ommen S.R. Evaluation of left ventricular filling pressures by Doppler echocardiography in patients with hypertrophic cardiomyopathy: correlation with direct left atrial pressure measurement at cardiac catheterization. Circulation 116 (2007) 2702-2708